ArticleThe Journal of investigative dermatology2015

XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation.

Manali Phadke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.